Risk Management & Pharmacovigilance

An effective REMS program improves patient access to medication.
Annette Stemhagen, DrPH, FISPE, Senior Vice President, Safety, Epidemiology, Registries & Risk Management - February 14, 2017
The EXL Risk Evaluation & Mitigation Strategy Summit, held at the end of January, was an opportunity for colleagues across the industry to discuss many topics related to REMS, including benefit-risk counseling between patients and...
2017 pharmaceutical industry predictions
UBC - January 03, 2017
After weighing in on the biggest trends from the last year, we asked a few of our experts to predict the forces that would shape the industry in 2017. Optimizing the Value of Healthcare The focus of 2017 will be about realizing the...
2016 Trends in Pharma
UBC - December 13, 2016
If 2016 had an overriding theme it was one of instability. This sense of volatility manifested in a variety of ways from political clashes to Brexit, and the pharmaceutical industry was not immune. What remains constant is the...
NextLevel 2016
, Scientific Consultant - November 01, 2016
Last week, medical affairs leaders gathered in London for NextLevel’s Medical Affairs Forum. At the congress, I was honored to chair the Best Practices in Late Phase Research track and meet with many industry leaders. Presenters...
ISPOR EU 2016
UBC - October 20, 2016
Vienna is known for its rich musical history and stunning imperial palaces, but next week the City of Music will draw crowds for ISPOR’s Annual European Congress.  From scientific presentations and consultations to sightseeing...
Tagged in:

Pages